Difference between revisions of "WSI21-139-Case-16"

From MGH Learn Pathology
(Created page with "{{ServiceRequestCase |requisition=Cytology |subject=MGH |intent=order |basedOn=WSI21-139 |priority=routine |code=study |orderDetail=case |authoredOn=December 09, 2022 04:51:51...")
 
(Added status template)
 
(One intermediate revision by one other user not shown)
Line 25: Line 25:
 
|reasonCode=Papanicolaou
 
|reasonCode=Papanicolaou
 
|view=show
 
|view=show
|modality=mrxs
+
|modality=tiff
 
}}
 
}}
 
{{Media
 
{{Media
Line 35: Line 35:
 
|reasonCode=Papanicolaou
 
|reasonCode=Papanicolaou
 
|view=show
 
|view=show
|modality=mrxs
+
|modality=tiff
 
}}
 
}}
 
{{Media
 
{{Media
Line 46: Line 46:
 
|view=show
 
|view=show
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Est105
 +
|authoredOn=December 09, 2022 04:51:51 PM
 
}}
 
}}

Latest revision as of 14:10, December 9, 2024

WSI21-139-Case-16
hx of Li-Fraumeni syndrome- IDC grade 3, poorly differentiated adrenal cortical carcinoma, leiomyosarcoma now with enlarged lymph nodes including left axillary lymph node Imaging showed a rupture left breast implant
reactive changes consistent with a rupture implant
No results